June 2026– date –
-
REPROCELL Standardizes and Streamlines PBMC Processing for Multi-Site Clinical Trials with Semi-Automated, Closed Systems and Fully Automated Microfluidic Platforms
REPROCELL Japan Overview A REPROCELL article addresses challenges in Peripheral Blood Mononuclear Cell (PBMC) processing for multi-site clinical trials by introducing innovative solutions to enhance efficiency and standardization. Improv... -
Bailun Identifies Eppendorf’s Versatile Bioreactor Portfolio Among Top 19 Lab Bioreactor Manufacturers in 2026
Bailun China Overview An article by Bailun, "Top 19 Lab Bioreactor Manufacturers in 2026," highlights Eppendorf's extensive bioprocess portfolio and diverse product range. Eppendorf offers scalable bioreactor systems, single-use and glas... -
Made Scientific and Pluristyx Strengthen Alliance for iPSC Cell Therapy Manufacturing, Aiming to Reduce Rework and Accelerate Development Timelines
Made Scientific USA Overview Made Scientific and Pluristyx announced an enhanced strategic partnership to accelerate the development of iPSC-derived cell therapy candidates. This collaboration integrates Pluristyx's advanced iPSC platfor... -
Cytiva Achieves Enhanced mAb Variant Separation and Purity Using IEX and Multimodal Resins, Optimizing Elution pH with Capto SP ImpRes
Cytiva USA Overview Cytiva's latest research demonstrates a significant improvement in separating charged monoclonal antibody (mAb) variants and achieving higher purity using ion exchange (IEX) and multimodal resins. Specifically, optimi... -
Next-Gen Process Analytics and QC Elevate Bioprocessing Efficiency: Real-Time Raman Probes Enable Continuous Glucose and Lactate Monitoring
Technology Networks UK Overview A Technology Networks article highlights how next-generation Process Analytical Technology (PAT) and industrial Quality Control (QC) testing significantly enhance biopharmaceutical manufacturing efficiency... -
CombiCult® Platform Boosts iPSC-Derived NK Cell Production 10-Fold in Stirred-Tank Bioreactors for Allogeneic Solid Tumor Therapy
Frontiers Switzerland Overview A study published in Frontiers has identified a feeder-free, manufacturable protocol for generating iPSC-derived NK (iNK) cells using the CombiCult® high-throughput screening platform. Scaling up to stirred... -
Sprintex Pivots to AI Data Center Market, Leveraging Compressor Technology for Fuel Cells
EnkiAI Australia Overview ASX-listed Sprintex announced a strategic pivot to leverage its established compressor technology for the high-growth AI data center power and cooling markets. The company initiated collaborations with US and Eu... -
Metacon Fuels 50MW Green Hydrogen Project with Key Payment and Capital Release
MarketScreener スウェーデン Overview Swedish hydrogen technology firm Metacon has announced a crucial €1.2 million payment for equipment, alongside the release of previously restricted bank funds, significantly bolstering its 50MW electr... -
H-Power Sells Two LC30 Fuel Cell Generators to TAMGO for Testing in Saudi Arabia, Targeting Extreme Conditions
London Stock Exchange UK Overview H-Power plc announced a deal to sell two LC30 fuel cell generators to TAMGO in Saudi Arabia. These generators will undergo performance and customer testing in Saudi Arabia, after which TAMGO will conduct... -
ACME’s $4.2 Billion Green Hydrogen Hub in Oman Targets 2030 Commercial Operations
Tankterminals.com オマーン Overview India's ACME Group is advancing its $4.2 billion green hydrogen and ammonia project in Oman's Duqm Special Economic Zone, with Phase 2 slated for commercial operations in 2030 and Phase 3 in 2033. Upon...
